Valeo Pharma Projecting Record Revenues for Q2

Valeo Pharma Projecting Record Revenues for Q2

VALEO PHARMA PROJECTING RECORD REVENUES FOR SECOND QUARTER 2021 Record revenues and margins expected for Q2-21 Redesca® launch beginning to impact financial performance Respiratory sales force infrastructure well advanced in support of coming Enerzair® Breezhaler® and...